CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...
CVS Health (CVS): Reassessing Valuation After Raised 2025–2026 Guidance and New AI Consumer Platform
CVS Health (CVS) just put fresh numbers on the table, raising its outlook for 2025 and sketching out higher earnings in 2026, ...
CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...
The outlook suggests Rhode Island-based CVS expects to manage a volatile environment that has posed challenges for all three ...
CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...
CVS to Pay $37.8 Million to Settle Overbilling Claims - CVS Pharmacy, Inc. agreed to pay $37.8 million to settle several lawsuits ...
By Jonathan Stempel NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too ...
CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...
CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...
The pharmacy admits to wrong doing and will fork out more than $24 million to the federal government and the remainder will ...
NEW YORK — Federal prosecutors said CVS Pharmacy will pay $37.76 million to resolve accusations that the company repeatedly ...
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the stateWOONSOCKET, R.I., Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results